Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:1479-1480

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gross, G. J.

(Circulation. 1998;98:1479-1480.)
© 1998 American Heart Association, Inc.


Editorials

Recombinant Cardiac ATP-Sensitive Potassium Channels and Cardioprotection

Garrett J. Gross, PhD

From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.

Correspondence to Garrett J. Gross, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226. E-mail ggross@mcw.edu


Key Words: Editorials • potassium • calcium • hypoxia • ischemia • molecular biology

The ATP-dependent potassium channels (KATP channels) were originally identified in isolated membrane patches prepared from guinea pig ventricular myocytes by Noma1 in 1983. Since their discovery in cardiac cells, KATP channels have also been discovered in many other tissues, such as smooth muscle, skeletal muscle, pancreas, and brain, in which they have been shown to couple cellular metabolism to membrane electrical activity.2 Primarily on the basis of studies using pharmacological tools, openers of KATP channels have been shown to elicit cardioprotective effects, whereas KATP channel antagonists have been shown to block the cardioprotective effects of KATP channel openers and the powerful protective effect produced by single or multiple brief episodes of ischemia to reduce myocardial infarct size, a phenomenon called ischemic preconditioning.3 Because the results of these previous studies were obtained indirectly by the use of pharmacological agonists and antagonists, the results of the present study published by Jovanovic and colleagues4 in this issue of Circulation are particularly exciting and are relevant for helping to clearly define an important role for the endogenous KATP channel protein subunits in conferring the cardioprotective effects of KATP channel openers and ischemic preconditioning. In this elegant study by Jovanovic and coworkers, the authors transfected KATP-deficient COS-7 cells with the Kir 6.2/SUR 2A genes, which Okuyama et al5 recently showed to form functional KATP channels in HEK 293T cells and to possess the main properties of native KATP channels in terms of activation by pinacidil and nicorandil but not diazoxide, channel rundown, and regulation . . . [Full Text of this Article]